Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BFRI
#4520
Biofrontera Inc. - Common Stock
1.5
9
USD
+0.07%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+6.71%
Monthly Change
+34.75%
6 month change
+69.15%
Year Change
+84.88%
Previous Close
1.4
9
Open
1.5
9
Low
1.5
9
High
1.5
9
Volume
9
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
BFRI
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Current report, Q3 FY2024
2024.08.14
Biofrontera Inc. current report, Q3 FY2024
8-K
Quarterly report, Q2 FY2024
2024.08.14
Biofrontera Inc. quarterly report, Q2 FY2024
10-Q
Current report, Q2 FY2024
2024.06.24
Biofrontera Inc. current report, Q2 FY2024
8-K
Current report, Q2 FY2024
2024.06.14
Biofrontera Inc. current report, Q2 FY2024
8-K
1
2
3
4
5
News
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates
BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates
Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates
CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates
Urogen Pharma (URGN) Reports Q2 Loss, Tops Revenue Estimates
Biofrontera Inc. (BFRI) Shareholder/Analyst Call Prepared Remarks Transcript
Biofrontera Inc. (BFRI) Q1 2026 Earnings Call Transcript
Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates
Humacyte, Inc. (HUMA) Reports Q1 Loss, Misses Revenue Estimates
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss
Are Medical Stocks Lagging Align Technology (ALGN) This Year?